Rocuronium

Sold as Esmeron, Rocustetic, Sandoz rocuronium, Adco rocuronium, Covan rocuronium, Restan-rocuronium, Restan rocuronium, Rocuronium iv biotech, Esroc, Rocuronium fresenius, Rocuronium ( ) viatris, Ronia, Euronom, Trakeze, Meraxt, Immaroc, Rocuronium kiara, Rocuronium bromide RBC, Vataron

C₃₂H₅₃N₂O₄⁺529.80 g/mol

[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-Hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate

Drag to rotate. Structure from PubChem CID 441290.

Loading Wikipedia summary

Registration

Applicants: 16
Registrations: 27
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Msd (Pty) Ltd	Esmeron	50 mg, 100 mg	300192, 300193	S4	None
Sandoz South Africa (Pty) LtdCancelled	Rocustetic	50, 100	431135, 431136	S4	None
Dezzo Trading 392 (Pty) Ltd	Sandoz rocuronium	50, 100	431140, 431141	S4	None
Adcock Ingram Critical Care (Pty) Ltd2 of 6 cancelled	Adco rocuronium, Covan rocuronium, Restan-rocuronium, Restan rocuronium	50 mg, 100 mg	440134, 440135, 440136, 440137, 440138, 440139	S4	None
Biotech Laboratories (Pty) Ltd	Rocuronium iv biotech	50	440188	S4	None
Ranbaxy (SA) (Pty) LtdCancelled	Esroc	Not stated	450664	S4	None
Fresenius Kabi South Africa (Pty) Ltd2 of 3 cancelled	Rocuronium fresenius	25 mg/2,5 ml, 50 mg/5 ml, 100 mg/10 ml	460060, 460061, 460062	S4	None
Viatris South Africa (Pty) Ltd	Rocuronium ( ) viatris	10mg/ml 5ml	490591	S4	None
Macleods Pharmaceuticals SA (Pty) LtdCertificate held by Abex Pharmaceutica (Pty) Ltd	Ronia	1 ml	510970.969	S4	PI PIL
Activo Health (Pty) Ltd	Euronom	Not stated	530158	S4	None
Pharma Dynamics (Pty) Ltd	Trakeze	1 mL	530159.158	S4	PI PIL
Kahma Biotech (Pty) Ltd	Meraxt	10 mg/ml	540866	S4	None
Cipla Medpro (Pty) LtdCertificate held by Ruby Pharmaceuticals (Pty) Ltd	Immaroc	50mg	550102	S4	PI PIL
Kiara Health (Pty) Ltd	Rocuronium kiara	50 mg/ 5 ml, 100 mg/ 10 ml	561070, 561071	S4	None
RBC Pharmaceuticals (Pty) Ltd	Rocuronium bromide RBC	50 mg/5 ml	570359	S4	None
Innovata pharmaceuticals	Vataron	10 mg/ml	610186	S4	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Esmeron 50 MG EACH 5 ml CONTAINS ROCURONIUM BROMIDE 50 mg	50 mg	30019230/17.1/0192	Registered	S4	None
Esmeron 100 MG EACH 10,0 ml SOLUTION CONTAINS ROCURONIUM BROMIDE 100,0 mg	100 mg	30019330/17.1/0193	Registered	S4	None
Rocustetic 50 Each 5,0 ml Solution contains: Rocuronium Bromide 50,0 mg	50	43113543/17.1.1/1135	Cancelled	S4	None
Rocustetic 100 Each 10,0 ml Solution contains: Rocuronium Bromide 100,0 mg	100	43113643/17.1/1136	Cancelled	S4	None
Sandoz rocuronium 50 EACH 5,0 ml VIAL CONTAINS ROCURONIUM BROMIDE 50,0 mg	50	43114043/17.1/1140	Registered	S4	None
Sandoz rocuronium 100 EACH 10,0 ml VIAL CONTAINS ROCURONIUM BROMIDE 100,0 mg	100	43114143/17.1/1141	Registered	S4	None
Adco rocuronium 50 MG EACH 5,0 ml VIAL CONTAINS ROCURONIUM BROMIDE 50,0 mg	50 mg	44013444/17.1/0134	Registered	S4	None
Adco rocuronium 100 MG EACH 10,0 ml VIAL CONTAINS ROCURONIUM BROMIDE 100,0 mg	100 mg	44013544/17.1/0135	Registered	S4	None
Covan rocuronium 50 MG EACH 5,0 ml VIAL CONTAINS ROCURONIUM BROMIDE 50,0 mg	50 mg	44013644/17.1/0136	Registered	S4	None
Covan rocuronium 100 MG EACH 5,0 ml VIAL CONTAINS ROCURONIUM BROMIDE 100,0 mg	100 mg	44013744/17.1/0137	Registered	S4	None
Restan-rocuronium 50 MG EACH 5,0 ml VIAL CONTAINS ROCURONIUM BROMIDE 50,0 mg	50 mg	44013844/17.1/0138	Cancelled	S4	None
Restan rocuronium 100 MG EACH 10,0 ml VIAL CONTAINS ROCURONIUM BROMIDE 100,0 mg	100 mg	44013944/17.1/0139	Cancelled	S4	None
Rocuronium 50 iv biotech EACH 5,0 ml VIAL CONTAINS ROCURONIUM BROMIDE 50,0 mg	50	44018844/17.1/0188	Registered	S4	None
Esroc EACH VIAL CONTAINS ROCURONIUM BROMIDE 50,0 mg	Not listed	45066445/17.1/0664	Cancelled	S4	None
Rocuronium 25 mg/2,5 ML fresenius EACH 2,5 ml SOLUTION CONTAINS ROCURONIUM BROMIDE 25,0 mg	25 mg/2,5 ml	46006046/17.1/0060	Cancelled	S4	None
Rocuronium 50 mg/5 ML fresenius EACH 5,0 ml SOLUTION CONTAINS ROCURONIUM BROMIDE 50,0 mg	50 mg/5 ml	46006146/17.1/0061	Registered	S4	None
Rocuronium 100 mg/10 ML fresenius EACH 10,0 ml SOLUTION CONTAINS ROCURONIUM BROMIDE 100,0 mg	100 mg/10 ml	46006246/17.1/0062	Cancelled	S4	None
Rocuronium injection 10mg/ml (5ml) viatris Each 5,0 ml Vial contains: Rocuronium Bromide 50,0 mg	10mg/ml 5mlInjection	49059149/17.1/0591	Registered	S4	None
Ronia	1 mlSolution for injection or infusion.	510970.96951/17.1/0970.969Approved 30 April 2023	Registered	S4	PI PIL
Euronom EACH 1,0 ml SOLUTION CONTAINS ROCURONIUM BROMIDE 10,0 mg	Not listed	53015853/17.1/0158	Registered	S4	None
Trakeze EACH 1,0 ml SOLUTION CONTAINS: ROCURONIUM BROMIDE 10,0 mg	1 mLSolution for injection or infusion.	530159.15853/17.1/0159.158Approved 22 November 2023	Registered	S4	PI PIL
Meraxt 10 mg/ml EACH VIAL CONTAINS ROCURONIUM BROMIDE 50,0 mg	10 mg/ml	54086654/17.1/0866	Registered	S4	None
Immaroc EACH VIAL CONTAINS ROCURONIUM BROMIDE 50,0 mg	50mgSolution for injection	55010255/17.1/0102Approved 29 March 2022	Registered	S4	PI PIL
Rocuronium 50 mg/ 5 ML kiara EACH VIAL CONTAINS ROCURONIUM BROMIDE EQUIVALENT TO ROCURONIUM 50,0 mg	50 mg/ 5 ml	56107056/1.2.2/1070	Registered	S4	None
Rocuronium 100 mg/ 10 ML kiara EACH VIAL CONTAINS ROCURONIUM BROMIDE EQUIVALENT TO ROCURONIUM 100,0 mg	100 mg/ 10 ml	56107156/1.2.2/1071	Registered	S4	None
Rocuronium bromide 50 mg/5 ML injection RBC Each vial contains: Rocuronium Bromide 50,0 mg	50 mg/5 mlInjection	57035957/17.1/0359	Registered	S4	None
Vataron 10 mg/ml EACH 1,0 ml SOLUTION CONTAINS: ROCURONIUM BROMIDE 10,0 mg	10 mg/ml	61018661/17.1/0186	Registered	S4	None

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Rocuronium bromide

S4: Rocuronium
Consolidated Schedules 06 July 2026, line 7832

Pharmacological class: Peripherally acting muscle relaxants. (class 17.1)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Ronia, Macleods Pharmaceuticals SA (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsRonia, Macleods Pharmaceuticals SA (Pty) Ltd Patient information leaflet (PIL)For patients and carersRonia, Macleods Pharmaceuticals SA (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background